Abstract
IL-17, a cytokine initially cloned from memory CD+ T cells, is produced by Th17 cells, a new lineage of T cells that are controlled by the transcription factor RORγt, as well as γδ T cells, NK and NKT cells. IL-17A and IL-17F use both IL-17RA and IL-17RC for signaling. IL-17RA is widely expressed in myeloid cells, fibroblasts, and epithelium. IL-17RA signaling is critical for mucosal immunity in the lung against extracellular bacterial infection through the regulation of granulopoietic growth factors and CXC chemokines required for neutrophil recruitment, as well as antimicrobial protein expression in epithelium. Although IL-17RA has a limited role in controlling the primary response to intracellular pathogens such as Listeria monocytogenes or Mycobacterium tuberculosis, other intracellular bacteria such as Francisella tularensis require IL-17 to mediate Th1 immunity. Furthermore, in the setting of vaccine-induced immunity, IL-17 regulates the recruitment of Th1 cells and is required for optimal vaccine responses for both extracellular and intracellular pathogens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beck JM, Rosen MJ, Peavy HH (2001) Pulmonary complications of HIV infection. Report of the fourth NHLBI workshop. Am J Respir Crit Care Med 164:2120–2126
Gallant JE, Moore RD, Chaisson RE (1994) Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 120:932–944
Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM (1995) The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423–432
Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178:2249–2254
Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG et al (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178:2243–2247
Suzuki Y, Conley FK, Remington JS (1989) Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol 143:2045–2050
Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A (1993) Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A 90:6115–6119
Finkelman FD, Shea-Donohue T, Goldhill J, Sullivan CA, Morris SC, Madden KB et al (1997) Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol 15:505–533
Maizels RM, Yazdanbakhsh M (2003) Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 3:733–744
Sieling PA, Modlin RL (1994) Cytokine patterns at the site of mycobacterial infection. Immunobiology 191:378–387
Wolff AJ, O’Donnell AE (2001) Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 120:1888–1893
Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P (1993) CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 150:5445–5456
Yao Z, Fanslow WC, Seldin MF, Rousseau A-M, Painter SL, Comeau MR et al (1995) Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to novel cytokine receptor. Immunity 3:811–821
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593–2603
Schwarzenberger P, La Russa V, Miller A, Ye P, Huang W, Zieske A et al (1998) IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 161:6383–6389
Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z et al (2000) Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 164:4783–4789
Tan W, Huang W, Zhong Q, Schwarzenberger P (2006) IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation. J Immunol 176:6186–6193
Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P et al (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194:519–527
Forlow SB, Schurr JR, Kolls JK, Bagby GJ, Schwarzenberger PO, Ley K (2001) Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 98:3309–3314
Ley K, Smith E, Stark MA (2006) IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res 34:229–242
Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K (2005) Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:285–294
Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J et al (2000) IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 165:5814–5821
McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C et al (2005) Role of IL-17A, IL-17 F, and the IL-17 receptor in regulating growth-related oncogene-{alpha} and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 175:404–412
Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467–476
Laan M, Cui ZH, Hoshino H, Lötvall J, Sjöstrand M, Gruenert DC et al (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162:2347–2352
Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A (2003) IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 170:2106–2112
Ruddy MJ, Shen F, Smith JB, Sharma A, Gaffen SL (2004) Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 76:135–144
Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, Kim WU et al (2004) IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 6:R120–R128
Laan M, Lötvall J, Chung KF, Lindén A (2001) IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br J Pharmacol 133:200–206
Prause O, Laan M, Lötvall J, Lindén A (2003) Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol 462:193–198
Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D et al (2007) The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8:247–256
Shen F, Ruddy MJ, Plamondon P, Gaffen SL (2005) Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-{alpha}-induced genes in bone cells. J Leukoc Biol 77:388–399
Miyamoto M, Prause O, Sjöstrand M, Laan M, Lötvall J, Lindén A (2003) Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170:4665–4672
Hurst SD, Muchamuel T, Gorman DM, Gilbert JM, Clifford T, Kwan S et al (2002) New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 169:443–453
Hoshino H, Laan M, Sjöstrand M, Lötvall J, Skoogh BE, Lindén A (2000) Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo. J Allergy Clin Immunol 105:143–149
Casaulta C, Schoni MH, Weichel M, Crameri R, Jutel M, Daigle I et al (2003) IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis. Pediatr Res 53:313–319
Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238
Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279
Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424:793–796
Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA et al (2008) IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med 14:275–281
Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J et al (2009) Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31:799–810
Bai H, Cheng J, Gao X, Joyee AG, Fan Y, Wang S et al (2009) IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 183:5886–5895
Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677–688
Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5:521–531
Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ et al (2005) Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202:761–769
Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM et al (2005) IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175:788–795
Khader SA, Guglani L, Rangel-Moreno J, Gopal R, Junecko BA, Fountain JJ et al (2011) IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol 187:5402–5407
Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH et al (2003) CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 170:1958–1963
Mangan PR, Harrington LE, O’Quinn DB, Helms WS, Bullard DC, Elson CO et al (2006) Transforming growth factor-β induces development of the TH17 lineage. Nature 441:231–234
Huang W, Na L, Fidel PL, Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190:624–631
Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, Chu HW (2007) IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 9:78–86
Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ et al (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206:299–311
Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK et al (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332:65–68
Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C et al (2004) IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173:3482–3491
Infante-Duarte C, Horton HF, Byrne MC, Kamradt T (2000) Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165:6107–6115
Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ et al (2003) Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 170:4432–4436
Michel ML, Keller AC, Paget C, Fujio M, Trottein F, Savage PB et al (2007) Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J Exp Med 204:995–1001
Lockhart E, Green AM, Flynn JL (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177:4662–4669
Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y (2007) Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 178:4466–4472
Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321–330
Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331–341
Reynolds JM, Angkasekwinai P, Dong C (2010) IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev 21:413–423
Aggarwal S, Ghilardi N, Xie MH, De Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–1914
Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE et al (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8:369–377
Romano M, D’Souza S, Adnet PY, Laali R, Jurion F, Palfliet K et al (2006) Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine 24:3353–3364
Agger EM, Cassidy JP, Brady J, Korsholm KS, Vingsbo-Lundberg C, Andersen P (2008) Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection. Immunology 124(2):175–85
Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19:93–129
Scriba TJ, Kalsdorf B, Abrahams DA, Isaacs F, Hofmeister J, Black G et al (2008) Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 180:1962–1970
Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV et al (1994) Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271:698–702
Higgins SC, Jarnicki AG, Lavelle EC, Mills KH (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol 177:7980–7989
Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, Tzianabos A et al (2006) Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 74:2187–2195
Chen K, McAleer JP, Lin Y, Paterson DL, Zheng M, Alcorn JF et al (2011) Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 35:997–1009
McNeal MM, Basu M, Bean JA, Clements JD, Choi AH, Ward RL (2007) Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice. Virology 363:410–418
McNeal MM, Basu M, Bean JA, Clements JD, Lycke NY, Ramne A et al (2007) Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge. Vaccine 25:6224–6231
Smiley KL, McNeal MM, Basu M, Choi AH, Clements JD, Ward RL (2007) Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J Virol 81:3740–3748
McNeal MM, Stone SC, Basu M, Clements JD, Choi AH, Ward RL (2007) IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4(+) T cells from mice immunized with a chimeric VP6 protein. Viral Immunol 20:571–584
Acknowledgments
Funding for this project was provided, in part, by the Pennsylvania Department of Health, the Tobacco Formula Funding, and the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Basel
About this chapter
Cite this chapter
Khader, S.A., Kolls, J.K. (2013). IL-17 and Mucosal Host Defense. In: Quesniaux, V., Ryffel, B., Padova, F. (eds) IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity. Progress in Inflammation Research. Springer, Basel. https://doi.org/10.1007/978-3-0348-0522-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0522-3_15
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0521-6
Online ISBN: 978-3-0348-0522-3
eBook Packages: MedicineMedicine (R0)